Codexis ($CDXS) - 10 Biotech IPOs of 2010
IPO Amount: $78M
Date: April 22
Range: $13-$15
Actual price: $13
Scoop: Codexis develops enzymes that are used by drug manufacturers as well as in biofuels; it products have been used by drug companies like Bristol-Myers Squibb, Merck and Pfizer. The company planned a $100 million IPO to fund new technology purchases and expand its production capacity. Codexis managed to price at the bottom of its range, raising $78 million and selling its stock at $13 per share.
Comments